Terazosin
- Product NDC
- 50090-1559
- 11-digit product format
- 500901559
- Labeler code
- 50090
- Product ID
- 50090-1559_20c2b6cd-ed1d-4eb3-a143-5151902b9c30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2004-12-20
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50090-1559 | D | Discontinued by firm | 2026-08-10 | ||
| excluded package | package | 50090-1559 | 50090-1559-0 | D | Discontinued by firm | 2026-08-10 | |
| excluded package | package | 50090-1559 | 50090-1559-1 | D | Discontinued by firm | 2026-08-10 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075317-001 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 |
| A075317-002 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | |
| A075317-003 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | |
| A075317-004 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075317-001 | AB |
| A075317-002 | AB |
| A075317-003 | AB |
| A075317-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075317-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-003 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075317-004 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-003 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075317-004 | AB | 1 | d06236e962d9… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 975cd6e7-95ee-60f8-7c38-135ffbb09240 | Product name | 2 | 20260223 |
| 1bc6d1ac-ef0f-4fc6-8704-c443f03b274a | Product name | 1 | 20250311 |
| 8adc9826-3fee-6091-f1ee-af9fd6f9caf8 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-1559-0 | 2023-02-07 | TERAZOSIN CAPSULES, USP |
| 50090-1559-0 | 2023-02-07 | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 |
| 50090-1559-1 | 2023-02-07 | TERAZOSIN CAPSULES, USP |
| 50090-1559-1 | 2023-02-07 | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 |
| 50090-1559-0 | 2023-01-30 | TERAZOSIN CAPSULES, USP |
| 50090-1559-0 | 2023-01-30 | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 |
| 50090-1559-1 | 2023-01-30 | TERAZOSIN CAPSULES, USP |
| 50090-1559-1 | 2023-01-30 | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-1559-0 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | 31 | |
| 50090-1559-1 | Terazosin | 90 in 1 BOTTLE | CAPSULE | 90 | 31 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-1559-0 | EA - Each | 50090-1559 | 54f02752-c2c3-4422-9fb5-74f091567ed0 | 1 | 2018-11-06 |
| 50090-1559-1 | EA - Each | 50090-1559 | ac24bea4-2081-4533-b349-fd607134e69d | 1 | 2018-09-05 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-1559 | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [A-S MEDICATION SOLUTIONS] | 28 | Current NDC, Legacy NDC, 2 package rows | 20240810_83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 458b4a60-b2d6-445a-8638-7fcd07decf66 | 2026-06-30 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | REMEDYREPACK INC. | a3a5901a-6395-4030-a27b-1fb17cd97315 | 2026-05-19 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | REMEDYREPACK INC. | 242589f0-0c79-4ea1-b900-10bccfec2b82 | 2026-05-19 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Jubilant Cadista Pharmaceuticals Inc. | 43e92495-2cf2-46dd-a80c-f0c3c88c7b73 | 2026-05-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 2c42171e-1b44-4d34-b6ca-5b6a94f0e694 | 2026-03-10 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin Hydrochloride | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | d971811c-d327-4e63-808c-8d553ee471e7 | 2026-03-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | REMEDYREPACK INC. | 854b64ff-c138-45af-9cdf-6c23323d8490 | 2026-01-08 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Coupler LLC | 4614e8cc-c922-4c0f-e063-6394a90a8501 | 2025-12-16 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 3822068f-f160-4493-a207-4d75dad6af73 | 2025-11-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | bb88f0d9-e010-4d4d-8465-bcccce0bef6e | 2025-11-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin hydrochloride | TERAZOSIN HYDROCHLORIDE | Preferred Pharmaceuticals, Inc | 9d8fd052-b478-447e-a884-74fcd21275bb | 2025-09-30 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 521e4aad-c6ec-4410-867f-dd9ecc08d5b2 | 2025-09-04 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 33699a94-4561-455f-9e5d-48856369aa07 | 2025-09-04 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | AvKARE | a2137488-8554-e84f-e053-2995a90a796c | 2025-07-23 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | AvPAK | 9e7b27a6-cc09-407e-e053-2a95a90a17b3 | 2025-07-02 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | A-S Medication Solutions | 4b195327-10d4-477f-ada2-d62c7f835e6c | 2024-11-07 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 40e5ae44-708a-15a3-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 363a6c85-e5e9-4521-9065-37a7c45bb525 | 2024-02-06 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 85e450c2-1bc3-49f4-ac2b-5aeedc154bba | 2024-02-01 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 0574d9ae-04da-4cb2-b124-9d920012c411 | 2023-07-20 | Warnings, Adverse reactions | 075317 ANDA075317 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 260376 | terazosin HCl 10 MG Oral Capsule | PSN | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313217 | terazosin HCl 2 MG Oral Capsule | PSN | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313219 | terazosin HCl 5 MG Oral Capsule | PSN | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 260376 | terazosin 10 MG Oral Capsule | SCD | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313217 | terazosin 2 MG Oral Capsule | SCD | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313219 | terazosin 5 MG Oral Capsule | SCD | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 260376 | terazosin (as terazosin HCl) 10 MG Oral Capsule | SY | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313217 | terazosin (as terazosin HCl) 2 MG Oral Capsule | SY | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
| 313219 | terazosin (as terazosin hydrochloride) 5 MG Oral Capsule | SY | 83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78 | 31 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-1559-0 | 50090155900 | 30 CAPSULE in 1 BOTTLE (50090-1559-0) | 30 capsule | 2014-12-19 | 0000-00-00 | No | No | Current |
| 50090-1559-1 | 50090155901 | 90 CAPSULE in 1 BOTTLE (50090-1559-1) | 90 capsule | 2014-12-19 | 0000-00-00 | No | No | Current |